BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1226@pharmaconomics
DTSTAMP:20260707T051212Z
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260310
SUMMARY:NBP Phase 2 — VIS-101
DESCRIPTION:Phase 2 trial results for VIS-101 in wet age-related macular degeneration (wet AMD) are due Mar 9\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1778016/000119312526097536/nbp-ex99_2.htm\n\nTrack it: https://www.pharmaconomics.com/e/1226
URL:https://www.pharmaconomics.com/e/1226
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:NBP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR